Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

DTC Comments Support FDA’s Goals; PhRMA Watching “Boundaries”

Executive Summary

FDA should remove language in its "disease awareness" advertising guidance suggesting the agency can take action against sponsors of "help-seeking" ads if they are the only manufacturer of a product to treat the disease, the Pharmaceutical Research & Manufacturers of America said

You may also be interested in...



Ads Linking “Help-Seeking” and Full Product Spots Helps Consumers – Pfizer

Similarities between branded ads and disease awareness ads may benefit consumers and should not be prohibited by FDA, Pfizer says

Ads Linking “Help-Seeking” and Full Product Spots Helps Consumers – Pfizer

Similarities between branded ads and disease awareness ads may benefit consumers and should not be prohibited by FDA, Pfizer says

FDA Disease Awareness Ad Policy Is Unfair To Small Firms, BIO Says

Restrictions on disease awareness advertisements proposed by FDA will hurt small biotech firms, the Biotechnology Industry Organization said

Related Content

UsernamePublicRestriction

Register

IV001392

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel